Personalis

$27.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.53 (+5.83%) Today

-$0.52 (-1.88%) As of 5:13 AM EST after-hours

Why Robinhood?

You can buy or sell Personalis and other stocks, options, and ETFs commission-free!

About PSNL

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. The listed name for PSNL is Personalis, Inc. Common Stock.

CEO

John S. West

Employees

182

Headquarters

Menlo Park, California

Founded

2011

Market Cap

1.08B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.13M

High Today

$28.01

Low Today

$25.93

Open Price

$26.46

Volume

450.36K

52 Week High

$32.80

52 Week Low

$4.27

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

PSNL Earnings

-$0.89

-$0.59

-$0.30

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 25, After Hours